News
Even when considering a slightly longer timeframe, ORCL stock has skyrocketed an astonishing 3x since early 2023, propelled ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
CoreWeave leases data center space from Core Scientific and previously tried to acquire the company last year.
Traders should now watch $250 as the next key level. A drop to that price would represent a 20% pullback from recent highs ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
U.S. stock futures eased Monday after a three-day break, after President Donald Trump said he would start sending out letters ...
Chinese electric vehicles are becoming far more attractive, rendering Tesla's cars less appealing, particularly in global ...
Prosus N.V. remains a strong buy with 80% gains since Feb 2024, attractive valuation, and significant growth potential for ...
An analyst downgrades Wells Fargo’s stock and upgrades U.S. Bancorp as regional banks gain favor after big runups by the ...
A lot has been said about the emerging technology's world-changing potential: Its ability to create stunningly realistic ...
Jazz Pharmaceuticals plc is a Buy with its robust portfolio, potential FDA approvals, and innovative oncology treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback